The Goldman Sachs Group Inc (GOS)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 818.80 |
|---|---|
| 52-week range | 661.10 – 1,006.00 |
| Return, 1 month / 3 months | +1.2% / −10.5% |
| Return, 1 year / 3 years | +22.5% / +214.9% |
| Trend | Below its 200-day average |
| RSI (14) | 55 |
| Volatility (1 year) | 30.0% |
| Worst drawdown (1 year) | -20.6% |
| Average daily value traded | 0.37M EUR |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
The Goldman Sachs Group is a financial institution based in New York that serves corporations, governments, institutions and individuals. It advises clients on mergers, acquisitions and other corporate transactions, helps companies raise money by underwriting securities offerings, and makes markets in stocks, bonds, currencies and commodities. The firm also manages investment funds and provides wealth and consumer banking services. Its clients include large companies, pension funds, sovereign entities and wealthy individuals around the world.
The Goldman Sachs Group Inc trades under the code GOS on the Deutsche Börse Xetra in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
The Goldman Sachs Group Inc (GOS) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 818.80 on 27 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 254 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.5% and over the last three months it fell 10.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.8% | ||
| From 52-week high | -17.3% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -10.5% | ||
| 6-month return | 4.3% | ||
| 12-month return, skipping the last month | 21.1% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.6% | ||
| Liquidity | 62 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.37M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.6% |
|---|---|
| 1 month | +1.2% |
| 3 months | −10.5% |
| 6 months | +4.3% |
| 1 year | +22.5% |
| 3 years | +214.9% |
| 5 years | +158.6% |
Signals
| 50-day / 200-day average | 833.59 / 825.15 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 16.73 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Sep 2026 | USD 4.4475 |
| 1 Jun 2026 | USD 4.0028 |
| 2 Mar 2026 | USD 4.0028 |
| 2 Dec 2025 | USD 3.5580 |
| 29 Aug 2025 | USD 3.5580 |
| 30 May 2025 | USD 2.6685 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.